feeling shaky on semaglutide Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Ozempic Tremors: Why Some Users

Regulatory & Safety Disclosure FDA Status: Compounded Semaglutide and Tirzepatide are not FDA-approved

Weight loss medications can affect fetal development and should be avoided during these stages

Medications primarily for type 2 diabetes For patients primarily managing type 2 diabetes, the conversation centers around improving glycemic control: Ozempic: Approved for adults with type 2 diabetes

This is because semaglutide continues to help control appetite and prevent overeating, even after the initial weight loss phase

The study protocol for the proteomic analyses was approved by the ethics committee for the Region of Southern Denmark (number H-21046833